Earlier detection of ovarian cancer

Deep Learning-Assisted Intelligent Artificial Vision Platform Based on Dual-Luminescence Eu(III)-Functionalized HOF for the Diagnosis of Breast and Ovarian Cancer

“…Breast and ovarian cancer, as the two cancers with the highest incidence rate and mortality among female malignant tumors, are seriously threatening the health of women around the world. , Breast cancer is often called the “pink killer” because of its high incidence. The global cancer statistics indicate that about 2.3 million women worldwide are diagnosed with breast cancer every year, accounting for 24.5% of female malignant tumors. , Ovarian cancer, as the most lethal gynecological malignancy and the fifth leading reason for women’s death associated with cancer, is known as the “king of gynecological cancer.” Ovarian cancer has always been a severely underestimated hidden killer, with about 70% of ovarian cancer being in its terminal stage when discovered because in the early stages, it remains silent and also there is a lack of effective screening methods . Therefore, early discovery is the key to improving the cure and survival rate of breast and ovarian cancer patients, which urgently needs to find a viable marker.…”